You are here: Industry Insights > Enlivex

News List

Enlivex: After Review of Phase II Data, Israeli Ministry of Health Authorizes Initiation of a Multi-Center, Randomized Phase IIb Clinical Trial Evaluating Allocetra in Severe and Critical COVID-19 Pat firstwordpharma
August 16, 2021
Enlivex Therapeutics Ltd. today reported that after reviewing previously-reported Phase II trial data, the Israeli Ministry of Health has authorized the initiation of a proposed Company-sponsored, multi-center, placebo-controlled, randomized, blinded
Enlivex Doses First Two Patients in Allocetra Trial in Severe COVID-19 Patients americanpharmaceuticalreview
October 29, 2020
Enlivex Therapeutics reported the first two patients have been dosed in an investigator-initiated Phase II clinical trial evaluating Allocetra in severe and critical COVID-19 patients.
Enlivex Announces First Patient Dosed in Allocetra Trial for COVID-19 with Respiratory Failure americanpharmaceuticalreview
August 13, 2020
Enlivex Therapeutics announced the first patient has been dosed in an investigator-initiated multi-center clinical trial of AllocetraTM in COVID-19 patients with severe illness and respiratory failures.
Enlivex Initiates Phase II Trial of Allocetra in COVID-19 contractpharma
May 08, 2020
Will assess Allocetra in combination with therapy in patients with lung dysfunction.